Rotem, Ran

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

Cesta, C. E., Rotem, R., Bateman, B. T., Chodick, G., Cohen, J. M., Furu, K., Gissler, M., Huybrechts, K. F., Kjerpeseth, L. J., Leinonen, M. K., et al. (2024) · JAMA Internal Medicine

Pregnancy and Medication ImpactGestational Diabetes Research and Management

Cited by 200

The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data

Chodick, G., Tene, L., Rotem, R. S., Patalon, T., Gazit, S., Ben-Tov, A., Weil, C., Goldshtein, I., Twig, G., Cohen, D., et al. (2022) · Clinical Infectious Diseases

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 176

Diabetes Mellitus, Obesity, and Diagnosis of Amyotrophic Lateral Sclerosis: A Population-Based Study

Kioumourtzoglou, M.-A., Rotem, R. S., Seals, R. M., Gredal, O., Hansen, J., & Weisskopf, M. G. (2015) · JAMA Neurology

Amyotrophic Lateral Sclerosis ResearchDementia and Cognitive Impairment Research

Cited by 145

Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study

Bardugo, A., Bendor, C. D., Rotem, R. S., Tsur, A. M., Derazne, E., Gerstein, H. C., Tzur, D., Pinhas-Hamiel, O., Cukierman-Yaffe, T., Raz, I., et al. (2023) · The Lancet Diabetes & Endocrinology

Gestational Diabetes Research and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 61